Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by G Di Perri
Plasma Concentrations of Boosted and Unboosted Atazanavir Are Predicted by 63396C>T SNP in the PXR Gene
Journal of the International AIDS Society
Environmental
Public Health
Infectious Diseases
Occupational Health
Related publications
Decrease of Atazanavir and Lopinavir Plasma Concentrations in a Boosted Double Human Immunodeficiency Virus Protease Inhibitor Salvage Regimen
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
No Difference in Effectiveness of Treatment Simplification to Boosted or Unboosted Atazanavir Plus Lamivudine in Virologically Suppressed in HIV-1-infected Patients
PLoS ONE
Multidisciplinary
Switching to Unboosted Atazanavir Improves Glucose Tolerance in Highly Pretreated HIV-1 Infected Subjects
European Journal of Endocrinology
Medicine
Endocrinology
Metabolism
Diabetes
Raltegravir With Unboosted Atazanavir 300 Mg Twice Daily in Antiretroviral Treatment-Experienced Participants
Journal of the International Association of Physicians in AIDS Care
Candidate SNP Markers of Aggressiveness-Related Complications and Comorbidities of Genetic Diseases Are Predicted by a Significant Change in the Affinity of TATA-binding Protein for Human Gene Promoters
BMC Genomics
Biotechnology
Genetics
Short Communication: Aging Not Gender Is Associated With High Atazanavir Plasma Concentrations in Asian HIV-Infected Patients
AIDS Research and Human Retroviruses
Virology
Infectious Diseases
Immunology
The Relationship of Insulin Resistance With SNP 276G>T at Adiponectin Gene and Plasma Long-Chain Polyunsaturated Fatty Acids in Obese Children
Pediatric Research
Child Health
Pediatrics
Perinatology
External Validation of the Bilirubin–Atazanavir Nomogram for Assessment of Atazanavir Plasma Exposure in HIV-1-Infected Patients
AAPS Journal
Pharmaceutical Science
Cancer-Gene Data Sharing Boosted
Nature
Multidisciplinary
